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Aims: We sought to evaluate RV function in bone marrow transplant (BMT) patients who have received anthracycline chemotherapy. Due to its thinner wall, we hypothesised that the right ventricle (RV) may show evidence of toxicity earlier, thus allowing earlier diagnosis.
Method: 68 BMT patients were retrospectively analysed; 47 patients had received anthracyclines. BMT patients were compared to 31 age and gender matched healthy controls. RV systolic function was assessed using conventional parameters including TAPSE, s' and RV fractional area change (FAC), as well as 2-dimensional RV free wall strain.
Results: TAPSE (21.1±3.7 vs 24.5±3.7 cm, p = 0.001), FAC (38.8±5 vs 43.8±5%, p < 0.0001) and RV free wall strain (28.1±2.8 vs 23.2±4.0%, p < 0.0001) were reduced in patients who had received anthracyclines compared with controls. Importantly, traditional RV function parameters failed to detect RV dysfunction as compared to RV free wall strain (i.e. 13 patients with preserved FAC and 12 patients with preserved TAPSE had reduced RV strain). Further, despite preserved LV function (LVEF >53% and GLS >17) a reduced RV GLS (<22%) was noted in 9 patients, all of whom had preserved FAC and TAPSE.
Conclusion: Traditional parameters of RV dysfunction were less sensitive than RV GLS strain to identify RV dysfunction. Additionally, RV function using strain identified RV subclinical dysfunction even in the absence of LV dysfunction. Background: The cause of cardiac conduction disturbance is often not determined before cardiac device implantation. Cardiovascular magnetic resonance (CMR) assesses cardiac structure and tissue characterisation, including fibrosis, though the value of routine CMR before a cardiac device is unknown.
Methods: Using CMR (1.5 Tesla), we performed an observational prospective study of 97 consecutive patients with a history of bradycardia, heart block, conduction disease and/or syncope prior to consideration of a pacemaker. We aimed to determine the incidence of cardiac abnormalities, and the relationship between late gadolinium enhancement (LGE) and incidence of device implantation. Statistical analysis was conducted using SPSSv25(IBM).
Results: CMR identified LGE in 37 patients, 28 of which had clinically significant CMR findings with previously undiagnosed: sarcoidosis (n = 4), old or acute myocarditis (n = 11), likely myocarditis or sarcoidosis (n = 5), myocardial infarction (n = 3), HCM (n = 1), DCM (n = 2), ARVC (n = 1) and Athlete's heart (n = 1). Of the 49 patients who received a cardiac device post CMR, 25 (51%) had myocardial LGE compared with 12 (25%) in the group without pacemaker (p = 0.012). In the group with pacemaker and LGE (n = 25), 21 (84%) had LGE in the interventricular septum which was strongly associated with pacemaker implantation (p = 0.007) and atrioventricular block (p = 0.039).
Conclusion: CMR identified a high rate of previously undiagnosed cardiac pathology in patients being considered for a pacemaker. The presence of LGE, particularly in the septum, was most associated with heart block and subsequent pacemaker implantation. CMR likely has a clinically significant role in routinely assessing patients before pacemaker implantation.
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